| Financial Year |
March 31 2023 |
| Monetary Funds |
1,582,014,395.16 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
269,704,088.12 |
| Advances to Suppliers |
236,177,160.27 |
| Other Receivables |
731,486,454.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
89,138.27 |
| Dividend Receivable |
-- |
| Inventories |
841,294,755.75 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
202,989,126.00 |
| Total Current Assets |
3,906,522,826.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,409,473,684.13 |
| Investment Properties |
7,490,704,368.80 |
| Fixed Assetes |
2,152,537,870.93 |
| Under-construction Projects |
2,362,160,080.31 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,427,451,217.58 |
| R&D expenses |
-- |
| Goodwill |
8,178,977.96 |
| Long-Term Deferred and Prepaid Expenses |
252,168,373.39 |
| Deferred Income Tax Assets |
90,918,551.21 |
| Other Non-Current Assets |
21,190,406.33 |
| Sub-Total of Non-Current Assets |
17,310,930,973.83 |
| Total Assets |
21,217,453,800.45 |
| Short-Term Loans |
4,845,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,266,309,483.58 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
380,583,341.84 |
| Taxes Payable |
144,799,265.49 |
| Interest Payable |
1,151,347.55 |
| Dividend Payable |
9,122,663.20 |
| Other payables |
1,084,879,996.24 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
321,680,284.62 |
| Other Current Liabilities |
31,305,408.98 |
| Sub-Total of Current Liabilities |
8,609,132,093.97 |
| Long-term Loans |
1,581,615,390.35 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
81,110,536.15 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
17,115,349.21 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,987,981,299.66 |
| Total Liabilities |
13,597,113,393.63 |
| Paid-In Capital(Or Share Stock) |
1,696,964,131.00 |
| Capital Surplus |
2,782,734,245.13 |
| Surplus Reserve |
358,346,168.45 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
991,581,286.57 |
| Minority Stockholder's Interest |
1,790,914,341.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,829,426,065.71 |
| Owner's Equity（Stockholder's Equity） |
7,620,340,406.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,217,453,800.45 |
